🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

Irisin as a Regulator of Brain Energy Homeostasis: Implications for Age-Related Neurodegenerative Diseases.

PMID: 41972693 · DOI: 10.3390/cells15070603 · Cells, 2026 · Bartosz Osuch, Patrycja Młotkowska, Elżbieta Marciniak, Tomasz Misztal
📄 Abstract

Aging is associated with disturbances in brain energy metabolism, mitochondrial dysfunction, and increased oxidative stress, all of which increase neuronal vulnerability and contribute to the development of neurodegenerative disorders. Growing evidence indicates that physical exercise exerts neuroprotective effects through the release of exerkines-exercise-induced signaling molecules that mediate communication between peripheral tissues and the brain. Among them, irisin, a proteolytic cleavage product of the membrane protein FNDC5, has emerged as an important mediator of the muscle-brain axis. This review summarizes current knowledge on the molecular mechanisms underlying irisin activity in the central nervous system, with particular emphasis on the AMPK-PGC-1α-FNDC5/BDNF signaling axis, rapid receptor-mediated pathways involving the cAMP/PKA/CREB and ERK/CREB cascades, and the regulation of mitochondrial homeostasis, including biogenesis, dynamics, autophagy, and mitophagy. Experimental studies suggest that irisin may improve neuroplasticity, neuronal survival, mitochondrial function, and reduce oxidative stress, thereby alleviating cognitive deficits in models of aging and neurodegeneration. Although the precise receptor mechanisms and intracellular signaling events remain incompletely understood, accumulating evidence identifies irisin as a promising therapeutic target linking metabolic adaptation with neuroprotection. Further investigation of irisin-dependent pathways may facilitate the development of novel strategies aimed at preserving brain function and delaying the progression of age-related neurodegenerative diseases.

Confidence: 0.25 · 13 полей извлечено
Идентификация (6 полей)
Target
irisin
1.00
Alt. target
FNDC5
1.00
Protein family
fibronectin type III domain-containing protein
0.90
Functional class
0.00
Subcellular loc.
membrane
0.90
Isoforms (metab/obesity)
0.00
Механизм действия (21 полей)
Mechanism
Irisin acts through the AMPK-PGC-1α-FNDC5/BDNF signaling axis and rapid receptor-mediated pathways involving cAMP/PKA/CREB and ERK/CREB cascades, regulating mitochondrial homeostasis including biogenesis, dynamics, autophagy, and mitophagy.
0.90
Mutations (obesity/lean)
0.00
Activity (obesity)
0.00
Activity temporal
0.00
Energy balance
Irisin is a regulator of brain energy homeostasis and is involved in metabolic adaptation.
0.80
Appetite
0.00
Fat metabolism
0.00
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
0.00
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
Irisin is a peptide hormone released during muscle contraction and mediates communication between peripheral tissues and the brain as part of the muscle-brain axis.
0.90
Cell death
Irisin may improve neuronal survival.
0.70
Adipocyte fibrosis
0.00
Upstream (biochem)
AMPK, PGC-1α, cAMP, PKA, ERK
0.80
Upstream (physiol)
Physical exercise
0.90
Downstream (biochem)
BDNF, CREB, mitochondrial homeostasis pathways
0.80
Downstream (physiol)
Neuroplasticity, neuronal survival, mitochondrial function, oxidative stress reduction, cognitive function
0.80
PTMs
Proteolytic cleavage of FNDC5 to produce irisin
0.90
Экспрессия (8 полей)
Tissue expression
0.00
In vitro
0.00
In vivo
0.00
In silico
0.00
Genetic association
0.00
Ex vivo
0.00
Animal model
0.00
Diet/model
0.00
Клиника (11 полей)
Drug
0.00
Indication
0.00
Patient subgroups
0.00
Safety concerns
0.00
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
0.00
Endpoints
0.00
Approved
0.00